Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices 35309 

1 50 U.S.C. 4558(c)(1). 

2 85 FR 18403 (Apr. 1, 2020). 

3 DHS Delegation 09052, Rev. 00.1 (Apr. 1, 2020); 

DHS Delegation Number 09052 Rev. 00 (Jan. 3, 

2017). 

4 85 FR 50035 (Aug. 17, 2020). The Attorney 

General, in consultation with the Chairman of the 

Federal Trade Commission, made the required 

finding that the purpose of the voluntary agreement 

may not reasonably be achieved through an 

agreement having less anticompetitive effects or 

without any voluntary agreement and published the 

finding in the Federal Register on the same day. 85 

FR 50049 (Aug. 17, 2020). 

5See 85 FR 78869 (Dec. 7, 2020). See also 85 FR 

79020 (Dec. 8, 2020). 

biology, computational toxicology, 

neurotoxicology, genetic toxicology, 

reproductive toxicology or teratology, 

and biostatistics. Members serve 

overlapping terms of up to four years. 

The BSC usually meets periodically. 

The authority for the BSC is provided by 

42 U.S.C. 217a, section 222 of the Public 

Health Service Act (PHS), as amended. 

The BSC is governed by the 

provisions of the Federal Advisory 

Committee Act, as amended (5 U.S.C. 

app.), which sets forth standards for the 

formation and use of advisory 

committees. 

Dated: June 29, 2021. 

Brian R. Berridge, 

Associate Director, National Toxicology 

Program. 

[FR Doc. 2021–14238 Filed 7–1–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; From 

Genomic Association to Causation: A 

Convergent Neuroscience Approach for 

Neuropsychiatric Disorders (U19). 

Date: July 28, 2021. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: David W. Miller, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd, Room 6140, MSC 9608, 

Bethesda, MD 20892–9608, 301–443–9734, 

millerda@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.242, Mental Health Research 

Grants, National Institutes of Health, HHS) 

Dated: June 29, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–14222 Filed 7–1–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Docket ID FEMA–2020–0016] 

Meetings To Implement Pandemic 

Response Voluntary Agreement Under 

Section 708 of the Defense Production 

Act 

AGENCY: Federal Emergency 

Management Agency, Department of 

Homeland Security. 

ACTION: Announcement of meetings. 

SUMMARY: The Federal Emergency 

Management Agency (FEMA) is holding 

a series of meetings to implement the 

Voluntary Agreement for the 

Manufacture and Distribution of Critical 

Healthcare Resources Necessary to 

Respond to a Pandemic. 

DATES: The schedule for these meetings 

is as follows: 

• The first meeting took place on 

Tuesday, June 22, 2021, from 2 to 4 p.m. 

Eastern Time (ET). 

• The second meeting took place on 

Wednesday, June 23, 2021, from 11 a.m. 

to 1 p.m. ET. 

• The third meeting took place on 

Tuesday, June 29, 2021, from 2 to 4 p.m. 

ET. 

• The fourth meeting took place on 

Thursday, July 1, 2021, from 2 to 4 p.m. 

ET. 

• The fifth meeting will take place on 

Tuesday, July 20, 2021, from 11 a.m. to 

1 p.m. ET. 

• The sixth meeting will take place 

on Thursday, July 22, 2021, from 2 to 4 

p.m. ET. 

• The seventh meeting will take place 

on Tuesday, August 3, 2021, from 11 

a.m. to 1 p.m. ET. 

• The eighth meeting will take place 

on Thursday, August 5, 2021, from 2 to 

4 p.m. ET. 

FOR FURTHER INFORMATION CONTACT: 

Robert Glenn, Office of Business, 

Industry, Infrastructure Integration, via 

email at OB3I@fema.dhs.gov or via 

phone at (202) 212–1666. 

SUPPLEMENTARY INFORMATION: Notice of 

these meetings is provided as required 

by section 708(h)(8) of the Defense 

Production Act (DPA), 50 U.S.C. 

4558(h)(8), and consistent with 44 CFR 

part 332. 

The DPA authorizes the making of 

‘‘voluntary agreements and plans of 

action’’ with representatives of industry, 

business, and other interests to help 

provide for the national defense.1 The 

President’s authority to facilitate 

voluntary agreements with respect to 

responding to the spread of COVID–19 

within the United States was delegated 

to the Secretary of Homeland Security 

in Executive Order 13911.2 The 

Secretary of Homeland Security further 

delegated this authority to the FEMA 

Administrator.3

On August 17, 2020, after the 

appropriate consultations with the 

Attorney General and the Chairman of 

the Federal Trade Commission, FEMA 

completed and published in the Federal 

Register a ‘‘Voluntary Agreement, 

Manufacture and Distribution of Critical 

Healthcare Resources Necessary to 

Respond to a Pandemic’’ (Voluntary 

Agreement).4 Unless terminated earlier, 

the Voluntary Agreement is effective 

until August 17, 2025, and may be 

extended subject to additional approval 

by the Attorney General after 

consultation with the Chairman of the 

Federal Trade Commission. The 

Agreement may be used to prepare for 

or respond to any pandemic, including 

COVID–19, during that time. 

On December 7, 2020, the first plan of 

action under the Voluntary 

Agreement—the Plan of Action to 

Establish a National Strategy for the 

Manufacture, Allocation, and 

Distribution of Personal Protective 

Equipment (PPE) to Respond to COVID– 

19 (PPE Plan of Action)—was finalized.5

The PPE Plan of Action established 

several sub-committees under the 

Voluntary Agreement, focusing on 

different aspects of the PPE Plan of 

Action. 

On May 24, 2021, four additional 

plans of action under the Voluntary 

Agreement—the Plan of Action to 

Establish a National Strategy for the 

Manufacture, Allocation, and 

Distribution of Diagnostic Test Kits and 

other Testing Components to respond to 

COVID–19, the Plan of Action to 


lotter on DSK11XQN23PROD with NOTICES1